Table 1.
Demographic characteristics of our study cohort.
| Demographic profile | CC group N = 111 | MC group N = 106 | P-value |
|---|---|---|---|
| Age (years) | |||
| <52 | 36 (33%) | 40 (37%) | 0.32 |
| >52 | 75 (67%) | 66 (63%) | |
| Matching | |||
| 9/10 (5 patients HLA DQ MM) | 26 (25%) | 27 (23%) | 0.57 |
| 10/10 | 85 (75%) | 79 (77%) | |
| Disease risk index | |||
| Intermediate | 81 (72%) | 83 (78%) | 0.34 |
| High risk | 30 (28%) | 23 (22%) | |
| Disease type | |||
| Myeloid | 104 (93%) | 99 (93%) | 0.65 |
| Lymphoid | 7 (7%) | 7 (7%) | |
| Stem cell source | |||
| Peripheral blood | 109 (98%) | 104 (97%) | 0.30 |
| Bone marrow | 2 (2%) | 2 (3%) | |
| Conditioning regimen | |||
| Reduced intensity | 58 (52%) | 64 (60%) | 0.25 |
| Myeloablative | 53 (48%) | 42 (40%) | |
pDLI pre-emptive donor lymphocyte infusion, MC mixed chimerism, CC complete chimerism, MM mismatch.